Rating Change
Scotiabank reiterated its Sector Outperform rating on Pfizer Inc. (NYSE:PFE) on October 06, 2026.
reiterateNYSE:PFE
Scotiabank Reiterates Sector Outperform Rating on Pfizer Inc. (PFE)
Scotiabank reiterated its Sector Outperform rating on Pfizer Inc. (NYSE:PFE) on October 06, 2026.
At publication ·
What changed
Pfizer Inc. (NYSE:PFE) · reiterate
- Firm
- Scotiabank
- Rating
- Sector Outperform to Sector Outperform
- Price at event
- $27.49
- Market capitalization
- $146.7B
At a glance
Key takeaways
- Scotiabank reiterated a Sector Outperform rating on Pfizer on October 6, 2026, with the stock trading at $27.48 and a market cap of $146.7 billion.
- Pfizer gained 8.7% over the past 52 weeks, and recent analyst coverage shows 4 Buy and 6 Hold ratings among the 10 most recent assessments.
- Analyst ratings and price targets are one input among many for investment decisions, with mixed historical predictive power on their own.
Market Context
Pfizer Inc. operates in the Healthcare sector. The stock currently trades at $27.48 with a market capitalization of $146.7B. The stock has gained 8.7% over the past 52 weeks.
Analyst coverage from Scotiabank provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Pfizer Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Pfizer Inc.
Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 06, 2026 | Scotiabank | Sector Outperform | N/A |
| Sep 10, 2026 | HSBC | Hold | N/A |
| Aug 07, 2026 | Guggenheim | Buy | N/A |
| Jul 13, 2026 | Guggenheim | Buy | N/A |
| Jul 13, 2026 | BMO Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View PFE Stock Page
Frequently Asked Questions
What does the Sector Outperform rating mean for PFE?
A rating of Sector Outperform from Scotiabank reflects the analyst's outlook on Pfizer Inc. (NYSE:PFE). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PFE forecast page.
Loading related coverage…
